Learning from combination HIV prevention programmes to face COVID-19 emerging pandemic

Full metadata record
DC FieldValueLanguage
dc.contributorCentro de Ensaios Clínicos e Farmacovigilânciapt_BR
dc.contributor.authorPalacios, Ricardopt_BR
dc.contributor.authorMathias, Augustopt_BR
dc.date.accessioned2020-09-24T19:14:48Z-
dc.date.available2020-09-24T19:14:48Z-
dc.date.issued2020pt_BR
dc.identifier.citationPalacios R, Mathias A. Learning from combination HIV prevention programmes to face COVID-19 emerging pandemic. Colomb Med.. 2020 May;51(2):e-4276. doi:10.25100/cm.v51i2.4276.pt_BR
dc.identifier.urihttps://repositorio.butantan.gov.br/handle/butantan/3198-
dc.description.abstractBefore a vaccine against SARS-CoV-2 became available, several measures to control COVID-19 pandemic are necessary. Analogously, in the absence of an available vaccine, Combination HIV Prevention Programmes have consolidated a large experience of biomedical, behavioral and structural interventions suitable for several epidemiological settings. Adaptation of such experiences can organize mid-term and long-term responses to face COVID-19.pt_BR
dc.format.extente-4276pt_BR
dc.language.isoEnglishpt_BR
dc.language.isoSpanishpt_BR
dc.relation.ispartofColombia Médicapt_BR
dc.rightsOpen accesspt_BR
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/pt_BR
dc.titleLearning from combination HIV prevention programmes to face COVID-19 emerging pandemicpt_BR
dc.title.alternativeAprender de los programas combinados de prevención del VIH para enfrentar la pandemia emergente COVID-19pt_BR
dc.typeArticlept_BR
dc.rights.licenseCC BY-NC-NDpt_BR
dc.identifier.doi10.25100/cm.v51i2.4276pt_BR
dc.identifier.urlhttps://doi.org/10.25100/cm.v51i2.4276pt_BR
dc.contributor.external(USP) Universidade de São Paulopt_BR
dc.identifier.citationvolume51pt_BR
dc.identifier.citationissue2pt_BR
dc.subject.keywordCOVID-19pt_BR
dc.subject.keywordcoronaviruspt_BR
dc.subject.keywordSARS Viruspt_BR
dc.subject.keywordCondomspt_BR
dc.subject.keywordAcquired Immunodeficiency Syndromept_BR
dc.subject.keywordPandemicspt_BR
dc.subject.keywordAsymptomatic Infectionspt_BR
dc.subject.keywordPersonal Protective Equipmentpt_BR
dc.subject.keywordsevere acute respiratory syndrome coronavirus 2pt_BR
dc.subject.keywordSevere Acute Respiratory Syndromept_BR
dc.subject.keywordimmunizationpt_BR
dc.subject.keywordVIHpt_BR
dc.relation.ispartofabbreviatedColomb Medpt_BR
dc.identifier.citationabntv. 51, n. 2, e-4276, maio. 2020pt_BR
dc.identifier.citationvancouver2020 May;51(2):e-4276pt_BR
dc.contributor.butantanPalacios, Ricardo|:Centro de Ensaios Clínicos e Farmacovigilância|:Pesquisador|:PrimeiroAutor:Autor de correspondênciapt_BR
dc.identifier.bvsccBR78.1pt_BR
dc.identifier.bvsdbIBProdpt_BR
dc.description.abstractesAntes de que una vacuna contra el SARS-CoV-2 esté disponible, son necesarias varias medidas para controlar la pandemia de COVID-19. Análogamente, en ausencia de una vacuna disponible, los Programas Combinados de Prevención del VIH han consolidado una gran experiencia de intervenciones biomédicas, conductuales y estructurales adecuadas para varios entornos epidemiológicos. La adaptación de tales experiencias puede organizar respuestas a medio y largo plazo para enfrentar COVID-19pt_BR
dc.description.dbindexedYespt_BR
item.fulltextCom Texto completo-
item.languageiso639-1English-
item.languageiso639-1Spanish-
item.openairetypeArticle-
item.grantfulltextopen-
crisitem.author.dept#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.dept#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.orcid0000-0002-1410-8579-
crisitem.author.orcid#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.parentorg#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.journal.journalissn#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.journal.journaleissn#PLACEHOLDER_PARENT_METADATA_VALUE#-
Appears in Collections:Artigos


Files in This Item:

10.25100cm.v51i2.4276.pdf
Description:
Size: 859.26 kB
Format: Adobe PDF
View/Open
Show simple item record

This item is licensed under a Creative Commons License Creative Commons